Ocugen, Inc.
DE ˙ DB ˙ US67577C1053
1,13 € ↓ -0,02 (-2,09%)
2026-06-04
DEL PRIS
SecurityDE:2H51 / Ocugen, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership677,906 shares
Latest Disclosed Value $ 1,227,010
Morgan Stanley reports 46.27% increase in ownership of 2H51 / Ocugen, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 677,906 shares of Ocugen, Inc. (DE:2H51) valued at $1,062,279 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 463,454 shares of Ocugen, Inc.. This represents a change in shares of 46.27% during the quarter. The current value of the position is $763,322 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F OCUGEN COM 67577C105 677,906 214,452 46.27 1,227 96.32 0.0001
2026-05-27 2025-12-31 13F/A-1 OCUGEN COM 67577C105 463,454 172,890 59.50 626 32.14 0.0000
2026-02-13 2025-12-31 13F OCUGEN COM 67577C105 463,454 172,890 626 0.0000
2026-05-27 2025-09-30 13F/A-1 OCUGEN COM 67577C105 290,564 -321,134 -52.50 474 -20.24 0.0000
2025-11-14 2025-09-30 13F OCUGEN COM 67577C105 290,564 -321,134 474 0.0000
2025-08-15 2025-06-30 13F OCUGEN COM 67577C105 611,698 -231,699 -27.47 594 -0.34 0.0000
2025-05-15 2025-03-31 13F OCUGEN COM 67577C105 843,397 -101,224 -10.72 596 -21.71 0.0000
2025-05-15 2024-12-31 13F/A-1 OCUGEN COM 67577C105 944,621 -16,806 -1.75 760 -20.25 0.0001
2025-02-14 2024-12-31 13F OCUGEN COM 67577C105 944,621 -16,806 760 0.0001
2025-05-14 2024-09-30 13F/A-2 OCUGEN COM 67577C105 961,427 333,768 53.18 954 -1.95 0.0001
2025-02-14 2024-09-30 13F/A-1 OCUGEN COM 67577C105 961,427 333,768 954 0.0001
2024-11-14 2024-09-30 13F OCUGEN COM 67577C105 961,427 333,768 954 0.0001
2025-05-14 2024-06-30 13F/A-2 OCUGEN COM 67577C105 627,659 8,254 1.33 973 -4.24 0.0001
2024-10-17 2024-06-30 13F/A-1 OCUGEN COM 67577C105 627,659 8,254 973 0.0001
2024-08-14 2024-06-30 13F OCUGEN COM 67577C105 627,659 8,254 973 0.0001
2024-10-17 2024-03-31 13F/A-2 OCUGEN COM 67577C105 619,405 323,236 109.14 1,016 497.06 0.0001
2024-08-16 2024-03-31 13F/A-1 OCUGEN COM 67577C105 619,405 323,236 1,016 0.0001
2024-05-15 2024-03-31 13F OCUGEN COM 67577C105 619,405 323,236 1,016 0.0001
2024-08-16 2023-12-31 13F/A-1 OCUGEN COM 67577C105 296,169 15,348 5.47 170 51.79 0.0000
2024-02-13 2023-12-31 13F OCUGEN COM 67577C105 296,169 15,348 170 0.0000
2023-11-15 2023-09-30 13F OCUGEN COM 67577C105 280,821 -68,793 -19.68 112 -40.74 0.0000
2023-08-14 2023-06-30 13F OCUGEN COM 67577C105 349,614 -48,166 -12.11 190 -44.25 0.0000
2023-05-15 2023-03-31 13F OCUGEN COM 67577C105 397,780 -48,917 -10.95 339 -41.55 0.0000
2023-02-14 2022-12-31 13F OCUGEN COM 67577C105 446,697 23,413 5.53 581 -22.97 0.0001
2022-11-14 2022-09-30 13F OCUGEN COM 67577C105 423,284 -2,092,933 -83.18 753 -86.81 0.0001
2022-10-27 2022-06-30 13F/A-1 OCUGEN COM 67577C105 2,516,217 496,040 24.55 5,711 -14.34 0.0007
2022-08-15 2022-06-30 13F OCUGEN COM 67577C105 2,516,217 496,040 5,711 0.0007
2022-10-27 2022-03-31 13F/A-1 OCUGEN COM 67577C105 2,020,177 1,414,556 233.57 6,667 141.91 0.0009
2022-05-13 2022-03-31 13F OCUGEN COM 67577C105 2,020,177 1,414,556 6,667 0.0009
2022-02-14 2021-12-31 13F OCUGEN COM 67577C105 605,621 -34,462 -5.38 2,756 -40.03 0.0003
2021-11-15 2021-09-30 13F OCUGEN COM 67577C105 640,083 51,013 8.66 4,596 -2.83 0.0006
2021-08-23 2021-06-30 13F/A-1 OCUGEN COM 67577C105 589,070 565,275 2,375.60 4,730 2,819.75 0.0006
2021-08-16 2021-06-30 13F OCUGEN COM 67577C105 589,070 565,275 4,730 0.0006
2021-05-17 2021-03-31 13F OCUGEN COM 67577C105 23,795 -40,992 -63.27 162 37.29 0.0000
2021-02-16 2020-12-31 13F OCUGEN COM 67577C105 64,787 48,832 306.06 118 2,260.00 0.0000
2020-11-13 2020-09-30 13F OCUGEN COM 67577C105 15,955 1,196 8.10 5 66.67 0.0000
2020-08-14 2020-06-30 13F OCUGEN COM 67577C105 14,759 14,759 3 0.0000
2019-08-14 2019-06-30 13F HISTOGENICS COM 43358V109 0 -1,406 -100.00 0 -100.00 0.0000
2019-05-15 2019-03-31 13F HISTOGENICS COM 43358V109 1,406 0 0.00 0 0.0000
2019-02-14 2018-12-31 13F HISTOGENICS COM 43358V109 1,406 -18,594 -92.97 0 -100.00
2019-04-23 2018-09-30 13F/A-2 HISTOGENICS COM 43358V109 20,000 0 0.00 11 -78.00 0.0000
2018-11-20 2018-09-30 13F/A-1 HISTOGENICS COM 43358V109 20,000 0 11 0.0000
2018-11-14 2018-09-30 13F HISTOGENICS COM 43358V109 20,000 0 11
2019-04-23 2018-06-30 13F/A-1 HISTOGENICS COM 43358V109 20,000 0 0.00 50 -9.09 0.0000
2018-08-14 2018-06-30 13F HISTOGENICS COM 43358V109 20,000 0 50
2019-04-23 2018-03-31 13F/A-1 HISTOGENICS COM 43358V109 20,000 20,000 55 0.0000
2018-05-14 2018-03-31 13F HISTOGENICS COM 43358V109 20,000 20,000 55
2016-08-12 2016-06-30 13F HISTOGENICS COM 43358V109 0 -574 -100.00 0 -100.00
2016-05-12 2016-03-31 13F HISTOGENICS COM 43358V109 574 1 0.17 1 -50.00 0.0000
2016-02-09 2015-12-31 13F HISTOGENICS COM 43358V109 573 -3,791 -86.87 2 -88.24 0.0000
2016-02-08 2015-09-30 13F/A-1 HISTOGENICS COM 43358V109 4,364 2,614 149.37 17 54.55 0.0000
2015-11-09 2015-09-30 13F HISTOGENICS COM 43358V109 4,364 17
2015-08-12 2015-06-30 13F HISTOGENICS COM 43358V109 1,750 -200 -10.26 11 -42.11 0.0000
2015-05-14 2015-03-31 13F HISTOGENICS COM 43358V109 1,950 -1,000 -33.90 19 -40.62 0.0000
2015-02-13 2014-12-31 13F HISTOGENICS COM 43358V109 2,950 2,950 32 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.